Clinical Trials List
Protocol NumberC1071032
Active
2025-05-01 - 2028-12-31
Phase III
Recruiting2
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- PO-HSIEN LI Division of Hematology & Oncology
- PO-WEI LIAO Division of Hematology & Oncology
- CHENG-HSIEN LIN Division of Hematology & Oncology
- HSIN-CHEN LIN Division of Hematology & Oncology
- 鄧齡喬 Division of Hematology & Oncology
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- Chieh-Lin Teng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王幸婷 Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
492 participants
